0.00Open0.01Pre Close0 Volume558 Open Interest45.00Strike Price0.00Turnover8480.87%IV71.79%PremiumApr 4, 2025Expiry Date0.00Intrinsic Value100Multiplier-7DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type0.0060Delta0.0030Gamma2620.00Leverage Ratio-16.2056Theta0.0000Rho15.60Eff Leverage0.0000Vega
Moderna Stock Discussion
Moderna Reveals Breakthrough Data on JN.1 Vaccine and 5 More Disease Programs
Major Breakthrough: Pfizer Teams With Flagship to Develop AI-Driven Autoimmune Treatments
Gapping Up
$Corcept Therapeutics (CORT.US)$ surged over 60% after the company announced that its Phase 3 trial, ROSELLA, met its primary endpoint, improving progression-free survival in platinum-resistant ovarian cancer patients.
$QuantaSing Group (QSG.US)$ surged 20.18% in pre-market trading following a 12% increase on Friday. Last week, QuantaSing Group expanded into the pop toys market through the strategic acqui...
Breakthrough: Moderna Expands Beyond COVID as Australia Approves RSV Vaccine
No comment yet